Results 301 to 310 of about 3,996,783 (390)

In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2016
C. Mayorga   +20 more
semanticscholar   +1 more source

Nasal Mucosa Regeneration After Reboot Surgery: Electron Microscopy and Histology Insights in CRSwNP

open access: yesThe Laryngoscope, EarlyView.
CRSwNP often requires multiple treatments, with monoclonal antibodies (mAbs) and endoscopic sinus surgeries used to manage resistant cases. This study focused on five patients undergoing reboot surgery, analyzing mucosal regeneration through biopsies and clinical outcomes over 24 months. It revealed complete non‐scarred regeneration of the nasal mucosa,
Francesca Pirola   +8 more
wiley   +1 more source

Efficacy and safety of low‐dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double‐blind, multicenter phase 3 trial

open access: yesLipids, EarlyView.
Low‐dose atorvastatin combined with ezetimibe achieves superior LDL‐C reduction (44.8%) compared with equivalent or higher‐dose statin monotherapy in Korean patients, presenting a more effective and safer therapeutic strategy potentially applicable to broader Asian populations.
Tae Oh Kim   +19 more
wiley   +1 more source

Synthesis of Heterotelechelic Poly(N‐ethylglycine) Polymers: from Polypeptoid Lipid Conjugates to Protein‐Polymer Conjugates

open access: yesMacromolecular Rapid Communications, EarlyView.
Defined for conjugation. We report the synthesis of heterotelechelic poly(N‐ethylglycine) (pNEtGly) via acid‐catalyzed polymerization of high‐purity NCA monomers. The resulting polymers exhibit excellent end‐group fidelity and enable well‐defined, high‐purity protein and lipid conjugates.
Ewout Buijs   +3 more
wiley   +1 more source

Does Drug-induced Hypersensitivity Syndrome Elicit Bullous Pemphigoid?

open access: gold, 2008
Akiko Kijima   +4 more
openalex   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

open access: yesMed Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin   +8 more
wiley   +1 more source

Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms. [PDF]

open access: yesJAAD Case Rep
Stratman S   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy